Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development.